UnitedHealth Q1 Earnings Beat, Shares Up 6.8%

UnitedHealth reported Q1 adjusted EPS $7.23, surpassing consensus $6.59, and revenue $111.7B beating $109.44B estimate.
Shares jumped over 6.8% in pre‑market trading, with analysts calling it the best quarterly print in years.
UnitedHealth guided FY2026 adjusted EPS of at least $18.25, topping the $17.87 consensus, and announced a $2 bn stock buyback by Q2.
Optum Rx revenue rose 2% to $35.7B, Optum Insight was flat at $5.1B, while Optum Health fell 3% to $24.1B.